Floatz logo

Folic Acid

Mild Cognitive Impairment

Jaime Daniel MondragonSmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
73/ 100

Competitive context

99 Active assets in the Mild Cognitive Impairment cohort.

Asset / SponsorPhaseRating
Sra-333
Helse Stavanger HF
Phase 4BBB
Metformin
Fudan University
Phase 4BB
Ginkgo Biloba
Dr. Willmar Schwabe GmbH & Co. KG
Phase 4BB
Ginkgo Biloba Extract
Hanyang University
Phase 4BB
Methylphenidate
St. Jude Children's Research Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Folic Acid is also rated in:

hyperhomocysteinemiaDormant
BBB
Indicative ·
76 / 100
View asset →
myocardial infarctionDormant
BBB
Indicative ·
72 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →